Navigation Links
Seahorse Bioscience, Inc. Appoints In Vitro Technologies Pty Ltd as New Distributor in Australia and New Zealand
Date:3/2/2011

NORTH BILLERICA, Mass., March 2, 2011 /PRNewswire/ -- Seahorse Bioscience, Inc., the leader in the design and development of instruments for assessing cellular bioenergetics, has announced In Vitro Technologies Pty Ltd as the new distributor of Seahorse XF Analyzers and consumables in Australia and New Zealand.

Seahorse Extracellular Flux Analyzers provide the first and only kinetic method to measure the two major energy producing pathways - mitochondrial respiration and glycolysis - in living cells in a microplate.

"In Vitro's Life Science product portfolio represents the highest quality laboratory instrumentation, equipment and consumables from around the world. With the interest in cellular bioenergetics in the Australia region the Seahorse brand is a perfect fit in our distribution strategy to focus on in vitro cell research," said Jennifer Parsons, Managing Director of In Vitro Technologies.

Seahorse XF Analyzers enable scientists to assess the impact of drugs, genetic modifications and environment by monitoring the rate that cells consume oxygen and produce metabolic byproducts.

"Our goal was to partner with a distributor who provides quality sales, service and support to customers in the cell based assay market," noted Steve Chomicz, VP Sales and Marketing for Seahorse. "The partnership with In Vitro will allow us to accelerate our sales as they have existing relationships with our ideal customer base."

About In Vitro Technologies Pty Ltd

In Vitro Technologies, founded in 2002, is a privately owned Scientific and Medical distribution company specializing in the sale and support of scientific, clinical diagnostic, medical and related products. The company is owned by JJ Richards & Sons Pty Ltd, one of Australia's largest employers with over 1,200 employees and revenues in excess of $300 million.

For more information, please visit http://www.invitro.com.au

About Seahorse Bioscience

Seahorse XF instruments have become the new standard in cellular bioenergetic measurements. Scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology & Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Neurodegeneration, Obesity, Diabetes, & Metabolic Disorders, Screening, and Translational Medicine. Seahorse is headquartered in Billerica, Massachusetts US.

For more information, please visit http://www.seahorsebio.com

Contact:  Cynthia Egan, Seahorse Bioscience, Inc., 1-978-671-1600, cegan@seahorsebio.com


'/>"/>
SOURCE Seahorse Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
2. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
3. Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference
4. TheScientist Awards Seahorse XF96 Analyzer a Top Ten Innovation for 2009
5. Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference
6. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
7. Omeros Appoints David A. Mann to its Board of Directors
8. RainDance Technologies Appoints Olex Vice President, System Development
9. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
10. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
11. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
(Date:3/18/2016)... --> --> Competitive Landscape Analysis ... Physical infrastructure and Perimeter Surveillance & Detection Systems ... and the continuing migration crisis in the Middle ... led visiongain to publish this unique report, which is crucial ... & security companies in the border security market and the ...
Breaking Biology News(10 mins):